Dr. Carlos R Becerra
Claim this profileGSK Investigational Site
Studies Solid Tumors
Studies Lung Cancer
6 reported clinical trials
10 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
KRAS positive
2Lung Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Carlos R Becerra is currently running
FL115
for Cancer
First-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies, including immune check-point inhibitors administered in single-agent or combination use.
Recruiting1 award Phase 112 criteria
NT-112
for Solid Tumors
This trial tests NT-112, a personalized immune cell treatment, in patients with advanced cancers that have a specific genetic mutation. The treatment boosts the patient's immune cells to target and kill cancer cells. This highly personalized cancer therapy involves giving the patient immune cells that directly attack cancer.
Recruiting1 award Phase 13 criteria
More about Carlos R Becerra
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Carlos R Becerra has experience with
- TSR-022
- Gemcitabine
- Nab Paclitaxel
- NovoTTF-100L(P)
- NovoTTF-200T
- Isunakinra
Breakdown of trials Carlos R Becerra has run
Colorectal Cancer
Cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carlos R Becerra specialize in?
Carlos R Becerra focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Carlos R Becerra currently recruiting for clinical trials?
Yes, Carlos R Becerra is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Carlos R Becerra has studied deeply?
Yes, Carlos R Becerra has studied treatments such as TSR-022, Gemcitabine, nab paclitaxel.
What is the best way to schedule an appointment with Carlos R Becerra?
Apply for one of the trials that Carlos R Becerra is conducting.
What is the office address of Carlos R Becerra?
The office of Carlos R Becerra is located at: GSK Investigational Site, Dallas, Texas 75246 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.